Treace Medical Concepts, Inc.
TMCI
$4.07
$0.010.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -91.20% | 42.33% | 6.38% | -9.27% | -3,078.04% |
| Total Depreciation and Amortization | -50.28% | -34.92% | 7.84% | 4.67% | 98.95% |
| Total Amortization of Deferred Charges | -75.49% | 1,325.33% | 1.35% | 0.00% | -93.12% |
| Total Other Non-Cash Items | -19.76% | 28.74% | -11.73% | 3.31% | -10.12% |
| Change in Net Operating Assets | 212.36% | -180.85% | -413.29% | -80.66% | 145.29% |
| Cash from Operations | 190.21% | 11.72% | -198.10% | -172.65% | 199.79% |
| Capital Expenditure | -27.69% | 14.63% | 41.07% | -34.55% | -15.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.41% | 4.50% | 664.57% | -8.43% | -74.61% |
| Cash from Investing | -180.86% | 10.65% | 368.22% | -71.96% | -155.36% |
| Total Debt Issued | -- | 10,305.26% | -42.01% | -- | -- |
| Total Debt Repaid | 99.18% | -13,768.95% | -317.35% | -- | -- |
| Issuance of Common Stock | 30.00% | -70.95% | 107.76% | -2.52% | 108.77% |
| Repurchase of Common Stock | -176.00% | 81.80% | -2,842.86% | 96.51% | -1,193.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.50% | -- | -- | -- | -- |
| Cash from Financing | -142.55% | 13,920.00% | -101.01% | 450.00% | -1,184.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.52% | 925.68% | 93.12% | -363.11% | 366.05% |